Evidence map›Paper›PMID 30323061›Full record

ArticleThe Journal of biological chemistry2018

The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial β-oxidation enzyme HADHA.

Dharendra Thapa, Kaiyuan Wu, Michael W Stoner, Bingxian Xie, Manling Zhang, Janet R Manning, Zhongping Lu, Jian H Li, Yong Chen, Marjan Gucek and 7 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Polycomb Repressive Complex 1 and USP16 localize to the mitochondrion and influence its function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. BLOC1S1 control of vacuolar organelle fidelity modulates TbioRxiv : the preprint server for biology · 2024
    Article
  16. The role of acetylation in obesity-induced cardiac metabolic alterations.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Dharendra ThapaFrom the Division of Cardiology; Vascular Medicine Institute; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Kaiyuan WuDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Michael W StonerFrom the Division of Cardiology; Vascular Medicine Institute; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Bingxian XieFrom the Division of Cardiology; Vascular Medicine Institute; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Endocrinology, Department of Medicine.
Manling ZhangFrom the Division of Cardiology; Vascular Medicine Institute; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Janet R ManningFrom the Division of Cardiology; Vascular Medicine Institute; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261.
Zhongping LuDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Jian H LiDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Yong ChenDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Marjan GucekDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Martin P PlayfordDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Nehal N MehtaDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Daniel HarmonCenter for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Endocrinology, Department of Medicine.
Robert M O'DohertyCenter for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Endocrinology, Department of Medicine.
Michael J JurczakCenter for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Endocrinology, Department of Medicine.
Michael N SackDivision of Intramural Research, NHLBI, National Institutes of Health, Bethesda, Maryland 20892.
Iain ScottFrom the Division of Cardiology; Vascular Medicine Institute; Center for Metabolism and Mitochondrial Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261. Electronic address: scotti2@upmc.edu.
University of Pittsburgh · USNational Institutes of Health · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Proteomics CoreZICHL005903 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GUCEK, MARJAN · 2009 to 2022
$23.3M
Mitochondrial Biology in DiseaseZIAHL005102 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SACK, MICHAEL · 2009 to 2025
$22.7M
Mitochondrial biology in diabetesZIAHL005199 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SACK, MICHAEL · 2009 to 2025
$17.2M
Role of intracellular organelle homeostasis in adaptation to dietary restrictive interventionsZIAHL006047 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SACK, MICHAEL · 2010 to 2025
$15.6M
T32 Research Training in Diabetes and EndocrinologyT32DK007052 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROBERT M O'DOHERTY · 1986 to 2026
$6.3M
Translational Pulmonary Vascular BiologyT32HL110849 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sruti Shiva · 2012 to 2026
$5.0M
Regulation of Fuel Utilization by Lysine Acetylation in the Failing HeartR01HL132917 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCOTT, IAIN · 2017 to 2020
$1.9M
Regulation of mitochondrial function by a novel lysine acetyltransferaseK22HL116728 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCOTT, IAIN · 2014 to 2016
$731k
Regulation of Fuel Utilization by Lysine Acetylation in the Failing HeartR56HL132917 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCOTT, IAIN · 2016 to 2016
$469k
Intramural NIH HHS ZIA HL005102Intramural NIH HHS ZIA HL005199Intramural NIH HHS ZIA HL006047NCI NIH HHS P30 CA047904NHLBI NIH HHS K22 HL116728NHLBI NIH HHS R01 HL132917NHLBI NIH HHS R56 HL132917NHLBI NIH HHS T32 HL110849NIDDK NIH HHS T32 DK007052
6 · The paper itself

Abstract

Sirtuin 3 (SIRT3) deacetylates and activates several mitochondrial fatty acid oxidation enzymes in the liver. Here, we investigated whether the protein acetylase GCN5 general control of amino acid synthesis 5-like 1 (GCN5L1), previously shown to oppose SIRT3 activity, is involved in the regulation of hepatic fatty acid oxidation. We show that GCN5L1 abundance is significantly up-regulated in response to an acute high-fat diet (HFD). Transgenic GCN5L1 overexpression in the mouse liver increased protein acetylation levels, and proteomic detection of specific lysine residues identified numerous sites that are co-regulated by GCN5L1 and SIRT3. We analyzed several fatty acid oxidation proteins identified by the proteomic screen and found that hyperacetylation of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit α (HADHA) correlates with increased GCN5L1 levels. Stable GCN5L1 knockdown in HepG2 cells reduced HADHA acetylation and increased activities of fatty acid oxidation enzymes. Mice with a liver-specific deletion of GCN5L1 were protected from hepatic lipid accumulation following a chronic HFD and did not exhibit hyperacetylation of HADHA compared with WT controls. Finally, we found that GCN5L1-knockout mice lack HADHA that is hyperacetylated at three specific lysine residues (Lys-350, Lys-383, and Lys-406) and that acetylation at these sites is significantly associated with increased HADHA activity. We conclude that GCN5L1-mediated regulation of mitochondrial protein acetylation plays a role in hepatic metabolic homeostasis.

Indexed as

AcetylationAnimalsDiet, High-FatFatty AcidsFatty LiverHep G2 CellsHumansLysineMice, Inbred C57BLMice, KnockoutMitochondrial ProteinsMitochondrial Trifunctional Protein, alpha SubunitNerve Tissue ProteinsOxidation-ReductionProtein IsoformsProtein Processing, Post-TranslationalBLOC1S1 protein, humanBLOC1S1 protein, mouseFatty AcidsHadha protein, mouseLysineMitochondrial ProteinsMitochondrial Trifunctional Protein, alpha SubunitNerve Tissue ProteinsProtein IsoformsSirt3 protein, mouseSirtuin 3acetylationfatty acid oxidationGCN5L1HADHAlipid metabolismliver metabolismmitochondriamitochondrial metabolismpost-translational modification (PTM)

Identifiers

PMID30323061
PMCPMC6240879
OpenAlexW2896380324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.